EUVIMEDEUVIMED entdecken
Crossref

Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer

Peiye Shen, Jing Ye, Han Ning Yee, Lu Zhang, Xiaoxiao Hu, Xiaoran Long, Premalatawati Krishna, Yen Ching Yeo, Huaiwu Lu, Wen Di, Ruoyu Shi, Xia Yin

Virchows Archiv · 20.03.2026

DOI: 10.1007/s00428-026-04477-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 20.03.2026. Verfasst von Peiye Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Ji…. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains a leading cause of cancer-related mortality in women, with locally advanced disease posing significant therapeutic challenges. This study evaluated the prognostic significance of tumor budding (TB) and residual viable tumor (RVT) among 101 patients with locally advanced cervical cancer (LACC) treated with neoadjuvant chemotherapy (NACT) followed by radical surgery. Using the modified International Tumor Budding Consensus Conference (ITBCC) criteria, we found that the TB-positive subgroup had significantly worse overall survival (OS) in univariate analysis (HR = 8.57; P 10% (HR = 4.25; P = 0.024) were significant predictors of poorer recurrence-free survival (RFS). Multivariate analysis confirmed that RVT > 10% (HR = 3.66; P = 0.048) was an independent prognostic factor for RFS. These results support integrating TB and RVT assessment into the standard pathological evaluation of post-NACT surgical resection specimens from LACC patients.

Schlagwörter

Stichwörter der Autor:innen

Cervical cancerNeoadjuvant chemotherapyResidual viable tumorTumor budding

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pathology and Laboratory Medicine, Kandang Kerbau Women's and Children's Hospital, Singapore, Singapore.
  • Department of Pathology, Hospital Sultanah Aminah, Johor Bahru, Malaysia.
  • Department of Gynecologic Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Pathology, National University Hospital Singapore, Singapore, Singapore. shi_ruoyu@nuhs.edu.sg.

Zitieren

APA

Shen, P., Ye, J., Yee, H. N., Zhang, L., Hu, X., Long, X., Krishna, P., Yeo, Y. C., Lu, H., Di, W., Shi, R., & Yin, X. (2026). Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer. Virchows Archiv. https://doi.org/10.1007/s00428-026-04477-3

Vancouver

Shen P, Ye J, Yee HN, Zhang L, Hu X, Long X, et al. Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer. Virchows Archiv. 2026. doi:10.1007/s00428-026-04477-3

BibTeX
@article{Shen2026,
  author = {Shen, Peiye and Ye, Jing and Yee, Han Ning and Zhang, Lu and Hu, Xiaoxiao and Long, Xiaoran and Krishna, Premalatawati and Yeo, Yen Ching and Lu, Huaiwu and Di, Wen and Shi, Ruoyu and Yin, Xia},
  title = {Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer},
  journal = {Virchows Archiv},
  year = {2026},
  doi = {10.1007/s00428-026-04477-3}
}
Kostenlos starten →